Not Yet Recruiting NA INTERVENTIONAL 2-arm NCT05656209

LA Improves the Prognosis of Patients With ICVD After Surgery

Lactobacillus Acidophilus Improves the Prognosis (Cognitive Function) of Patients With Ischemic Cerebrovascular Disease After Surgery: a Prospective Randomized Controlled Study

Sponsor: Huaqiu Zhang

Conditions Cognitive Impairment Ischemia; Cerebrovascular

Interventions Lactobacillus acidophilus

Updated 3 times since 2023 Last updated: Dec 16, 2022 Started: Dec 18, 2022 Primary completion: Dec 18, 2022 Completion: Dec 31, 2027

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

This NA trial investigates Cognitive Impairment and Ischemia; Cerebrovascular and is currently actively recruiting participants. Huaqiu Zhang leads this study, which shows 3 recorded versions since 2022 — indicating limited longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.

Status Flow

Change History

3 versions recorded

Sep 2024 — Present [monthly]

Not Yet Recruiting NA
Jul 2024 — Sep 2024 [monthly]

Not Yet Recruiting NA
Jan 2023 — Jul 2024 [monthly]

Not Yet Recruiting NA

First recorded

Dec 2022

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Huaqiu Zhang

Data source: Tongji Hospital

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

No location information available.